Shanliang Li
- Clinical Biochemistry top 5%
- Nephrology top 10%
-
- Mitochondrial Function and Pathology 4
- Ginseng Biological Effects and Applications 2
- ATP Synthase and ATPases Research 2
-
- Nitric Oxide and Endothelin Effects 5
- Alzheimer's disease research and treatments 2
-
- Anesthesia and Pain Management 4
-
- Cardiac Ischemia and Reperfusion 4
-
- Anesthesia and Sedative Agents 3
- Journals
- Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)Hypertension (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Shanliang Li
19 papers receiving 896 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Clinical Biochemistry 98
- Nephrology 86
- Molecular Biology 552
- Physiology 178
- Cancer Research 76
Countries citing papers authored by Shanliang Li
This map shows the geographic impact of Shanliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanliang Li more than expected).
Fields of papers citing papers by Shanliang Li
This network shows the impact of papers produced by Shanliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanliang Li. The network helps show where Shanliang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shanliang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 10 | |
| 9 | 2018 | 11 | |
| 10 | 2017 | 9 | |
| 11 | 2017 | 15 | |
| 12 | Mitochondrial Fission Inhibitors Suppress Endothelin-1-Induced Artery Constrictionbreakdown → | 2017 | 608 |
| 13 | 2016 | 37 | |
| 14 | 2016 | 8 | |
| 15 | 2016 | 44 | |
| 16 | 2016 | 40 | |
| 17 | 2016 | 43 | |
| 18 | 2014 | 9 | |
| 19 | 2013 | 15 |
About Shanliang Li
Shanliang Li is a scholar working on Anesthesiology and Pain Medicine, Physiology and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 898 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (5 papers), Mitochondrial Function and Pathology (4 papers), Anesthesia and Pain Management (4 papers), Cardiac Ischemia and Reperfusion (4 papers), Anesthesia and Sedative Agents (3 papers), Ginseng Biological Effects and Applications (2 papers), Alzheimer's disease research and treatments (2 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Clinical Biochemistry (98 citations), Nephrology (86 citations) and Molecular Biology (552 citations). Shanliang Li has collaborated with scholars based in China and United States. Frequent co-authors include De‐Li Dong, Jin‐Lai Gao, Changlin Zhen, Xin Shen, Mingyu Liu, Xinzi Zhang, Yuanyuan Wei, Chang Chen, Jing Jin and Xiuchen Xuan. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.